KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) Times Interest Earned: 2013-2020

Historic Times Interest Earned for Xenon Pharmaceuticals (XENE) over the last 2 years, with Jun 2020 value amounting to -$4.19.

  • Xenon Pharmaceuticals' Times Interest Earned rose 85.43% to -$4.19 in Q2 2020 from the same period last year, while for Jun 2020 it was -$24.46, marking a year-over-year increase of 11.11%. This contributed to the annual value of -$64.67 for FY2020, which is 116.58% down from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Times Interest Earned stood at -$4.19 for Q2 2020, which was up 82.77% from -$24.34 recorded in Q1 2020.
  • In the past 5 years, Xenon Pharmaceuticals' Times Interest Earned ranged from a high of -$4.19 in Q2 2020 and a low of -$49.09 during Q1 2018.
  • Moreover, its 3-year median value for Times Interest Earned was -$28.80 (2019), whereas its average is -$28.46.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Times Interest Earned fell by 17.85% in 2019 and then surged by 85.43% in 2020.
  • Quarterly analysis of 3 years shows Xenon Pharmaceuticals' Times Interest Earned stood at -$20.92 in 2018, then dropped by 17.85% to -$33.33 in 2019, then spiked by 85.43% to -$4.19 in 2020.
  • Its Times Interest Earned was -$4.19 in Q2 2020, compared to -$24.34 in Q1 2020 and -$33.33 in Q4 2019.